The Archive · A Source
Yescarta Now Approved in Japan
Gilead Sciences / Kite Pharma 2022 www.gilead.com/news/news-details/2022/yescarta-now-approved-in-japan-for-initial-treatment-of-relapsedrefractory-large-b-cell-lymphoma
An Independent Reference on Medical Travel Abroad · Reader-Funded
The Archive · A Source
Gilead Sciences / Kite Pharma 2022 www.gilead.com/news/news-details/2022/yescarta-now-approved-in-japan-for-initial-treatment-of-relapsedrefractory-large-b-cell-lymphoma